These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Serum complement in human kidney diseases]. Lagrue G, Bariéty J, Halpern B, Milliez P. Pathol Biol; 1967 Apr; 15(7):378-83. PubMed ID: 4864895 [No Abstract] [Full Text] [Related]
3. [Alpha2-macroglobulin in the nephrotic syndrome]. Ado MA, Poliantseva LR, Mukhin NA, Tareeva IE, Dvoretskova LK. Ter Arkh; 1973 May; 45(5):94-7. PubMed ID: 4203442 [No Abstract] [Full Text] [Related]
4. [Lymphocyte metabolism and its relation to the pathogenesis of the nephrotic syndrome]. Komissarova IA, Poliantseva LR, Artem'eva VB, Kochubeĭ LN, Kudriashova NM. Vestn Akad Med Nauk SSSR; 1975 May; (6):48-52. PubMed ID: 1227110 [No Abstract] [Full Text] [Related]
5. [The function of the vascular endothelium in glomerulonephritis and amyloidosis]. Kozlovskaia LV, Poliantseva LR, Mukhin NA, Karryeva BCh, Maksimov NA. Ter Arkh; 1991 May; 63(6):31-3. PubMed ID: 1948739 [No Abstract] [Full Text] [Related]
6. Fibrin-fibrinogen degradation products in children with renal disease. Ambrus JL, Baliah T, Ambrus CM, Mink IB, Murphy GP. N Y State J Med; 1974 Jul; 74(8):1396-402. PubMed ID: 4277485 [No Abstract] [Full Text] [Related]
7. [Immunological properties of blood serum proteins in kinney diseases]. Starosel'tseva LK. Vopr Med Khim; 1966 Jul; 12(2):141-6. PubMed ID: 4176190 [No Abstract] [Full Text] [Related]
8. Cytostatic treatment of glomerular diseases. II. Effect of azathioprine on serum and urine proteins. Report from a Copenhagen Study Group of Renal Diseases. Balslov JT, Brun C, Jensen KB, Jorgensen F, Jorgensen HE, Larsen M, Lorenzen I, Thomsen AC. Acta Med Scand; 1973 Jun; 193(6):493-8. PubMed ID: 4721958 [No Abstract] [Full Text] [Related]
17. [The serum magnesium level in kidney diseases]. Klete H. Z Gesamte Inn Med; 1967 Dec 01; 22(23):756-62. PubMed ID: 5590637 [No Abstract] [Full Text] [Related]